Last reviewed · How we verify
Metastatic soft tissue sarcoma
Approved treatments
- Doxorubicin Hydrochloride · Pfizer Inc.
Doxorubicin intercalates nucleotide bases and interacts with topoisomerase II to form DNA-cleavable complexes, inhibiting DNA/RNA replication.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Metastatic soft tissue sarcoma patent landscape — cliff calendar, originator estates, attackable patents
- Metastatic soft tissue sarcoma treatment landscape brief
- Metastatic soft tissue sarcoma treatment updates RSS
Frequently asked questions about Metastatic soft tissue sarcoma
What drugs treat Metastatic soft tissue sarcoma?
Tracked treatments include Doxorubicin Hydrochloride.
What is the treatment for Metastatic soft tissue sarcoma?
Standard treatment for Metastatic soft tissue sarcoma includes Doxorubicin Hydrochloride. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Metastatic soft tissue sarcoma patent cliff · Metastatic soft tissue sarcoma CI report
- Treatment: Doxorubicin Hydrochloride · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing